Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

15.02M

Fund Score

Virtus LifeSci Biotech Clinical Trials ETF Price, Quotes and Forecasts | ARCA:BBC | Benzinga

Explore Virtus LifeSci Biotech Clinical Trials ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BBC.

Open	$20.05
High	$20.05
52 Wk High	$31.65
AUM	15.02M
Dividend	$0.24
Ex-Div Date	Dec 20, 2024
Volume	27.67K
Market Cap	$2.28B
Mgmt Fee	0.79%
P/E Ratio	8.61
Prev. Close	$20.03
Low	$19.24
52 Wk Low	$18.77
Shares Out	400.00K
Yield	1.20%
Div. Freq	Annual
Avg. Volume Daily	26.89K
Beta	1.03
Avg. Expense Ratio	0.79%
P/B Ratio	2.71

Recent News

Why Is uniQure Stock Skyrocketing On Tuesday?

uniQure stock surges after FDA agrees on an accelerated approval pathway for its Huntington's disease treatment, AMT-130.

Nabaparna Bhattacharya

Inflation Cools in June, Triggers Spike in Laggard ETFs

Inflation in the United States cooled down in June for the third consecutive month. The Consumer Price Index rose just 3% year over year last month, down from an annual growth of 3.3% in May. On a monthly basis, the index declined 0.1% from May's flat reading. This marked the first monthly drop in inflation since 2020 and the slowest annual price gain since March 2021.

Zacks

3 ETFs With Q2 Gains Of At Least 30%

The S&P 500 is sitting on an impressive 16.36% gain with just one day left in the second quarter. Arguably, that's a spectacular run considering the state of U.S. stocks in March at the hands of the coronavirus pandemic.

ETF Professor

FAQ

How do I buy Virtus LifeSci Biotech Clinical Trials ETF (BBC) stock?

You can purchase shares of Virtus LifeSci Biotech Clinical Trials ETF (ARCA:BBC) through any online brokerage.

View our list of the best stock brokerages

Who are Virtus LifeSci Biotech Clinical Trials ETF (BBC) competitors?

There are no as such competitors for Virtus LifeSci Biotech Clinical Trials ETF.

What is the forecast, or price target, for Virtus LifeSci Biotech Clinical Trials ETF (BBC) stock?

There is no analysis for Virtus LifeSci Biotech Clinical Trials ETF to provide a consensus price target.

What is the current price for Virtus LifeSci Biotech Clinical Trials ETF (BBC)?

The stock price for Virtus LifeSci Biotech Clinical Trials ETF (ARCA: BBC) is $19.8 last updated March 21, 2025 at 8:35 AM EDT.

Does Virtus LifeSci Biotech Clinical Trials ETF (BBC) pay a dividend?

A quarterly cash dividend of 0.30 per share of Class A Common Stock. The quarterly cash dividend was payable on December 27, 2017 to stockholders of record on December 20, 2017.

When is Virtus LifeSci Biotech Clinical Trials ETF (ARCA:BBC) reporting earnings?

Virtus LifeSci Biotech Clinical Trials ETF does not have any upcoming earnings scheduled.

Is Virtus LifeSci Biotech Clinical Trials ETF (BBC) going to split?

There is no upcoming split for Virtus LifeSci Biotech Clinical Trials ETF.

Open	$20.05
High	$20.05
52 Wk High	$31.65
AUM	15.02M
Dividend	$0.24
Ex-Div Date	Dec 20, 2024
Volume	27.67K
Market Cap	$2.28B
Mgmt Fee	0.79%
P/E Ratio	8.61
Prev. Close	$20.03
Low	$19.24
52 Wk Low	$18.77
Shares Out	400.00K
Yield	1.20%
Div. Freq	Annual
Avg. Volume Daily	26.89K
Beta	1.03
Avg. Expense Ratio	0.79%
P/B Ratio	2.71

About ETFis Series Trust I

Sector

N/A

Industry

N/A

ETF Details

Sector	Healthcare
Category	High Performer-Mid Growth
Investment Style	Small Cap Growth
Fund Inception	Dec 16, 2014
Managers	Seth Kadushin Paul Yook Andrew McDonald Matthew B. Brown
Definition	This equity fund portfolio contains majority of stocks with strong financial performance and average growth potential

Investment Policy

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Top ETF Holdings

Symbol	Name	Share %
RNA	Avidity Biosciences In...	2.84%
SMMT	Summit Therapeutics In...	1.11%
VKTX	Viking Therapeutics In...	2.75%
CGEM	Cullinan Oncology Inc	2.34%
DYN	Dyne Therapeutics Inc	2.29%
NVAX	Novavax Inc	2.24%
VERA	Vera Therapeutics Inc ...	2.19%
SYRE	Spyre Therapeutics Inc	0.76%
MRUS	Merus Nv	1.13%
ACLX	Arcellx, Inc.	1.36%
BLTE	Belite Bio, Inc	1.09%
SLRN	Acelyrin Inc	0.90%
NAMS	Newamsterdam Pharma Co...	0.88%
MLYS	Mineralys Therapeutics...	0.87%
NMRA	Neumora Therapeu	0.86%
GPCR	Structure Therapeutics...	0.55%
NGNE	Neurogene Inc - Series...	0.52%
PRME	Prime Medicine, Inc.	0.36%
AKRO	Akero Therapeutics Inc	1.57%
LQDA	Liquidia Corp.	1.43%
SANA	Sana Biotechnology Inc	1.26%
ARQT	Arcutis Biotherapeutic...	1.22%
ANAB	Anaptysbio Inc	1.13%
XERS	Xeris Biopharma Holdin...	1.12%
VIR	Vir Biotechnology Inc	1.12%
ETNB	89bio Inc	1.11%

Comments

Virtus LifeSci Biotech Clinical Trials ETF Stock Price, Quotes and Forecasts

Overview